Editorspicks
ZUG, Switzerland, Feb. 11, 2021 /CNW/ — Mind Medicine (MindMed) Inc. (NEO: MMED)(DE: BGHM)(OTCQB:MMEDF), a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds ... [Read]